Sagimet Biosciences Inc. (SGMT) Tops Q2 EPS by 25c

Sagimet Biosciences Inc. (NASDAQ: SGMT) reported Q2 EPS of ($0.25), $0.25 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Sagimet Biosciences Inc. (SGMT) click here.

You May Also Be Interested In

• Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
• Bolla Oil launches first loyalty program using PAR Technology platform
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance